Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

1.24
+0.06005.08%
Post-market: 1.21-0.0300-2.42%19:01 EDT
Volume:983.01K
Turnover:1.19M
Market Cap:254.20M
PE:-3.47
High:1.26
Open:1.19
Low:1.13
Close:1.18
Loading ...
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Jan 07, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 20, 2024

Correspondence

Form CORRESP - Correspondence
Dec 19, 2024

Correspondence

Form CORRESP - Correspondence
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Jul 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
May 30, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report